Randomized Phase II Study of Erlotinib in Combination With Placebo or R1507, a Monoclonal Antibody to Insulin-Like Growth Factor-1 Receptor, for Advanced-Stage Non–Small-Cell Lung...

Por Ramalingam, Suresh S., Spigel, David R., Chen, David, Steins, Martin B., Engelman, Jeffrey A., Schneider, Claus-Peter, Novello, Silvia, Eberhardt, Wilfried E.E., Crino, Lucio, Habben, Kai, Liu, Lian, Jänne, Pasi A., Brownstein, Carrie M., Reck, Martin
Publicado no J Clin Oncol (2011)